Pieris Pharmaceuticals, Inc. (PIRS)

NASDAQ: PIRS · IEX Real-Time Price · USD

11.72

+0.12 (1.03%)

At close: Apr 26, 2024, 4:00 PM

11.40

-0.32 (-2.73%)

After-hours: Apr 26, 2024, 7:30 PM EDT

Pieris Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Revenue	42.81	25.9	31.42	29.32	46.28	29.1	25.28	5.83	2.93	5.37	Upgrade
Revenue Growth (YoY)	65.28%	-17.56%	7.14%	-36.64%	59.03%	15.14%	333.46%	98.88%	-45.35%	-56.83%	Upgrade
Gross Profit	42.81	25.9	31.42	29.32	46.28	29.1	25.28	5.83	2.93	5.37	Upgrade
Selling, General & Admin	16.85	16.39	16.59	16.71	18.44	18.44	17.58	8.89	8.37	6.96	Upgrade
Research & Development	41.8	52.98	66.66	46.53	55	41.49	22.29	19.7	8.24	5.6	Upgrade
Other Operating Expenses	13.91	0	0	0	0	0	0	0	0	0	Upgrade
Operating Expenses	72.57	69.38	83.25	63.24	73.44	59.93	39.87	28.59	16.61	12.56	Upgrade
Operating Income	-29.76	-43.47	-51.83	-33.92	-27.16	-30.83	-14.59	-22.76	-13.68	-7.2	Upgrade
Interest Expense / Income	0	0	0	0	0	0	0	0	0.18	2.65	Upgrade
Other Expense / Income	-5.21	-10.2	-6.09	3.15	-1.69	-3.77	1.95	-0.12	-0.01	-0	Upgrade
Pretax Income	-24.54	-33.28	-45.74	-37.07	-25.47	-27.07	-16.54	-22.64	-13.85	-9.85	Upgrade
Income Tax	0	0	0	0.16	0	-0.31	1.1	0.16	0.2	-0	Upgrade
Net Income	-24.54	-33.28	-45.74	-37.23	-25.47	-26.75	-17.65	-22.8	-14.06	-9.85	Upgrade
Preferred Dividends	0	0	0	0	2.83	0	0	0	0	0	Upgrade
Net Income Common	-24.54	-33.28	-45.74	-37.23	-28.3	-26.75	-17.65	-22.8	-14.06	-9.85	Upgrade
Shares Outstanding (Basic)	1	1	1	1	1	1	1	1	0	0	Upgrade
Shares Outstanding (Diluted)	1	1	1	1	1	1	1	1	0	0	Upgrade
Shares Change	21.43%	14.91%	18.48%	7.62%	-4.63%	20.83%	5.32%	21.28%	147.92%	17.27%	Upgrade
EPS (Basic)	-21.60	-36.00	-56.80	-54.40	-44.80	-40.00	-32.00	-44.00	-32.80	-56.80	Upgrade
EPS (Diluted)	-21.60	-36.00	-56.80	-54.40	-44.80	-40.00	-32.00	-44.00	-32.80	-56.80	Upgrade
Free Cash Flow	-53.99	-60.97	-8.61	-48.62	-54.93	-2.76	47.8	-14.95	-13.33	-5.33	Upgrade
Free Cash Flow Per Share	-47.96	-65.76	-10.67	-71.40	-86.80	-4.17	87.05	-28.67	-31.00	-30.75	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-69.51%	-167.84%	-164.97%	-115.68%	-58.68%	-105.94%	-57.74%	-390.31%	-466.62%	-134.17%	Upgrade
Profit Margin	-57.33%	-128.47%	-145.58%	-126.97%	-61.15%	-91.93%	-69.82%	-391.00%	-479.50%	-183.59%	Upgrade
Free Cash Flow Margin	-126.12%	-235.40%	-27.40%	-165.82%	-118.69%	-9.50%	189.14%	-256.35%	-454.52%	-99.40%	Upgrade
EBITDA	-22.76	-30.5	-43.37	-34.94	-24.43	-26.5	-16.18	-22.28	-13.36	-6.83	Upgrade
EBITDA Margin	-53.17%	-117.74%	-138.04%	-119.15%	-52.79%	-91.05%	-64.00%	-382.03%	-455.75%	-127.27%	Upgrade
Depreciation & Amortization	1.78	2.78	2.37	2.13	1.04	0.57	0.37	0.36	0.31	0.37	Upgrade
EBIT	-24.54	-33.28	-45.74	-37.07	-25.47	-27.07	-16.54	-22.64	-13.67	-7.2	Upgrade
EBIT Margin	-57.33%	-128.47%	-145.58%	-126.41%	-55.03%	-93.01%	-65.46%	-388.22%	-466.25%	-134.11%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).